Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID)
Condition(s):Covid19; Sequelae of; Infection; Cognitive SymptomLast Updated:March 20, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Covid19; Sequelae of; Infection; Cognitive SymptomLast Updated:March 20, 2024Completed
Condition(s):Cognitive Function; Mood; SleepLast Updated:July 24, 2019Completed
Condition(s):PharmacokineticsLast Updated:September 9, 2014Completed
Condition(s):Chemotherapy-induced Peripheral NeuropathyLast Updated:January 19, 2024Active, not recruiting
Condition(s):BioavailabilityLast Updated:April 11, 2018Completed
Condition(s):Cognition Disorders in Old Age; Mild Cognitive Impairment; Cognitive DeclineLast Updated:December 21, 2022Completed
Condition(s):Diabetic Neuropathy PeripheralLast Updated:April 5, 2022Suspended
Condition(s):Chemotherapy-induced Peripheral Neuropathy; Breast Cancer Metastatic; Platinum-resistant Recurrent Ovarian Cancer; Head and Neck Cancer Stage IV; Endometrial Cancer Stage IVLast Updated:April 12, 2023Terminated
Condition(s):Mild Cognitive Impairment; NADLast Updated:September 2, 2021Completed
Condition(s):Aging; LipemiaLast Updated:September 25, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.